Published Online: July 29, 2015. doi:10.1001/jamasurg.2015.1340.
Study concept and design: Haut, Lau, Kraus, Maheshwari, Streiff.
Acquisition, analysis, or interpretation of data: Haut, Lau, Kraus, Hobson, Maheshwari, Streiff.
Drafting of the manuscript: Haut, Lau, Kraus, Maheshwari, Pronovost, Streiff.
Critical revision of the manuscript for important intellectual content: Haut, Kraus, Hobson, Maheshwari, Pronovost, Streiff.
Statistical analysis: Lau, Maheshwari.
Administrative, technical, or material support: Haut, Lau, Kraus, Streiff.
Study supervision: Haut, Kraus, Streiff.
Conflict of Interest Disclosures: Drs Haut, Streiff, and Pronovost and Mr Lau are supported by a contract from the Patient-Centered Outcomes Research Institute (CE-12-11-4489) entitled “Preventing Venous Thromboembolism: Empowering Patients and Enabling Patient-Centered Care via Health Information Technology.” Mr Lau is supported by a contract (AD-1306-03980) from the Patient-Centered Outcomes Research Institute entitled “Patient-Centered Approaches to Collect Sexual Orientation/Gender Identity Information in the Emergency Department.” Dr Streiff has received research funding from Bristol-Myers Squibb and honoraria for CME lectures from Sanofi; has consulted for Sanofi, Eisai, Daiichi-Sankyo, Boehringer Ingelheim, and Janssen HealthCare; and has given expert witness testimony in various medical malpractice cases. Dr Haut was the primary investigator of a Mentored Clinician Scientist Development Award (K08 1K08HS017952-01) from the Agency for Healthcare Research and Quality entitled “Does Screening Variability Make DVT an Unreliable Quality Measure of Trauma Care?” Dr Haut receives royalties from Lippincott, Williams, & Wilkins for the book Avoiding Common ICU Errors and has given expert witness testimony in various medical malpractice cases. Dr Haut is a paid consultant for the “Preventing Avoidable Venous Thromboembolism—Every Patient, Every Time” VHA IMPERATIV Advantage Performance Improvement Collaborative. Ms Hobson has given expert witness testimony in various medical malpractice cases. Dr Pronovost reports receiving grant or contract support from the Agency for Healthcare Research and Quality, the Gordon and Betty Moore Foundation (research related to patient safety and quality of care), the National Institutes of Health (acute lung injury research), and the American Medical Association (research related to improving blood pressure control); honoraria from various health care organizations for speaking on quality and patient safety (the Leigh Bureau manages these engagements); book royalties from the Penguin Group; and stock and fees to serve as a director for Cantel Medical. Dr Pronovost is a founder of Patient Doctor Technologies, a startup company that seeks to enhance the partnership between patients and clinicians with an application called Doctella. No other disclosures are reported.